Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2024-06-27

Clinical Trial Update: Autologous Blood Patch for Primary Spontaneous Pneumothorax [NA]

View source ↗

Summary

A clinical trial evaluating autologous blood patch for primary spontaneous pneumothorax has been withdrawn from the study database.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Autologous Blood Patch (autologous blood patch)

Snippet

Sponsor: Rush University Medical Center | Conditions: Primary Spontaneous Pneumothorax | NA | Status: WITHDRAWN